Solventum Corp. (SOLV)
91.90
+0.95
(+1.04%)
USD |
NYSE |
Sep 02, 16:00
91.10
-0.80
(-0.87%)
Pre-Market: 20:00
Solventum Cash from Investing (Quarterly) : -87.00M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -87.00M |
| March 31, 2026 | -77.00M |
| December 31, 2025 | -745.00M |
| September 30, 2025 | 3.766B |
| June 30, 2025 | -110.00M |
| March 31, 2025 | -114.00M |
| December 31, 2024 | -127.00M |
| Date | Value |
|---|---|
| September 30, 2024 | -93.00M |
| June 30, 2024 | -58.00M |
| March 31, 2024 | -102.00M |
| December 31, 2023 | -88.00M |
| September 30, 2023 | -6.00M |
| June 30, 2023 | -71.00M |
| March 31, 2023 | -65.00M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Stryker Corp. | -639.00M |
| Zimmer Biomet Holdings, Inc. | -190.80M |
| Edwards Lifesciences Corp. | -193.20M |
| Intuitive Surgical, Inc. | -26.60M |
| Inspire Medical Systems, Inc. | 3.548M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 227.00M |
| Cash from Financing (Quarterly) | -300.00M |
| Free Cash Flow | -118.00M |
| Free Cash Flow Per Share (Quarterly) | 0.8309 |
| Free Cash Flow to Equity (Quarterly) | 145.00M |
| Free Cash Flow to Firm (Quarterly) | 199.11M |
| Free Cash Flow Yield | -0.73% |